Health ❯ Chronic Diseases

Type 2 Diabetes

Heart Disease Obesity Treatment Options Risk Factors Risk Reduction Insulin Resistance Prevention Strategies Medications Management Strategies Obesity-Related Conditions Weight Management Colorectal Cancer Cardiovascular Diseases Management Insulin Sensitivity Obesity-related Conditions Cardiovascular Risks Probiotic Treatment Aspartame Dementia GLP-1 Agonists Metabolic Health Diagnostic Tools Metabolic Disorders Dietary Impact Prevention Obesity Management Comorbidities Insulin Regulation Preventive Measures Dietary Risk Factors Medication Effects Obesity Treatment Weight Loss Drugs Hypertension Breast Cancer Risk Medication Drug Therapies

AstraZeneca Strikes $1.2 Billion CSPC Pact for Once‑Monthly Obesity and Diabetes Programs

The lead asset SYH2082 is progressing into Phase 1 following the signing.

Gut Microbe Molecule TMA Inhibits IRAK4, Easing Diet-Driven Inflammation in Diabetes Models

Fatty Food Odors in Pregnancy Linked to Offspring Obesity Risk in Mouse Study

Brighter Nights Tied to Higher Cardiovascular Risk in 89,000-Person Wearable Study

7,000 Daily Steps Deliver Near-Maximal Health Benefits, Meta-Analysis Finds

Hims & Hers Plans Canadian Launch of Generic Semaglutide After Zava Acquisition

New Meta-Analysis Finds No Safe Level of Ultra-Processed Foods

Metabolic Subtypes Drive Individual Blood Sugar Responses to Carbs, Study Finds